You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A Novel Microfludic Device for Drug Toxicity Studies
SBC: CFD RESEARCH CORPORATION Topic: CBD10103Current drug discovery and development efforts are severely limited by expensive animal trials and oversimplified in vitro models. Results obtained from in vitro models are not predictive of in vivo toxicity owing to significant difference from the in vivo physiological conditions. In this context, we propose to develop and demonstrate a novel microfluidic device that reproduces the physiological ...
SBIR Phase II 2011 Department of DefenseOffice for Chemical and Biological Defense -
Chemical Warfare Agent (CWA) Lightweight Field-Portable (Hand-Held) Medical Diagnostic Tool
SBC: RAPID PATHOGEN SCREENING, INC. Topic: CBD06104The U.S. Army Medical Research Acquisition Activity at Fort Detrick, MD awarded an SBIR Phase I contract to Rapid Pathogen Screening, Inc. (RPS) in May 2006. The overall objective of this SBIR topic is to develop a lightweight field-portable (i.e., hand-held) device that fulfills a two-fold purpose as follows: (1) it will detect/identify Chemical Warfare Nerve Agents (CWNAs) of operational conce ...
SBIR Phase II 2007 Department of DefenseOffice for Chemical and Biological Defense -
Focal Plane Array Technology for Passive Hyperspectral Standoff Detection
SBC: EPIR TECHNOLOGIES INC Topic: CBD10105Chemical imaging sensors require focal plane arrays (FPAs) incorporating long wavelength infrared (LWIR) detectors suitable for hyperspectral detection. These detectors require high sensitivity to account for the low photon counts in narrow wavelength bands. The required sensitivity elevates the associated costs, so a need exists for a lower cost LWIR FPA for use with chemical imaging sensors. The ...
SBIR Phase II 2011 Department of DefenseOffice for Chemical and Biological Defense -
Hermetic Seals for Chemical/Biological Protective Garments
SBC: CREARE LLC Topic: CBD13109Interfaces on existing military chemical/biological protection garments are not designed to fully eliminate macroscopic and microscopic air gaps at folds, fabric surfaces, or hook-and-loop closures, and thus do not provide a hermetic barrier against exposure. Creare is developing hermetic garment closure systems that seal macroscopic and microscopic gaps at interfaces and closures and provide high ...
SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense -
Imidazenil: A Protective Agent Against Chemical Warfare Agents induced Status Epilepticus
SBC: NEUPHARMA, INC. Topic: CBD05116The overall objective of this Phase II proposal is to determine the advantages of imidazenil over diazepam or midazolam as a potential anticonvulsant agent for the prophylaxis and for the emergency treatment of organophosphate nerve agent exposure. Therefore, we will compare the dose-dependent efficacy and anticonvulsant tolerance liability of imidazenil or midazolam for protecting rats against di ...
SBIR Phase II 2007 Department of DefenseOffice for Chemical and Biological Defense -
Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point ofCare Applications
SBC: GENECAPTURE, INC. Topic: CBD15C001GeneCapture, Inc. is proposing to develop a rapid in vitro diagnostic prototype using our patented molecular-based CAPTURE (ConfirmActive Pathogens Through Unamplified RNA Expression) assay. Based on the results and experience gained in our Phase I STTR contractHDTRA1-16C-0061: Infectious Disease Diagnostics and Differentiation of Viral vs. Bacterial Infections for Point of Care Applications, we p ...
STTR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense -
Medical Countermeasure Development for Viral Induced Encephalitis Using Single DomainAntibodies
SBC: ABZYME THERAPEUTICS LLC Topic: CBD161004Alphaviruses, infection with which may cause encephalitis and death, are recognized as potential biological warfare agents. There are noapproved medical countermeasures against Alphaviruses. In Phase I, using Abzymes proprietary in vivo Self-Diversifying Camelid SingleDomain Antibody Library (SDALib) platform, broadly reactive single domain camelid VHH antibodies against equine encephalitis viral ...
SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense -
Microfiber-Based Closures with Hermetic Sealing for Chem Bio Protective Garments
SBC: NANOGRIPTECH Topic: CBD13109Future engagements (especially with near-peer threats) present the possibility of a wide range of anticipated operational situations involving the presence of chemical threat agents. With this, deployment of Military Working Dogs (MWDs) is likely. This creates a situational awareness that MWDs are potentially at risk from exposure to a wide range of hazardous chemicals. Potential threat agents inc ...
SBIR Phase II 2018 Department of DefenseOffice for Chemical and Biological Defense -
Microfluidic High-throughput Platform for Determining Kinetic Constants of Enzyme Variants
SBC: CFD RESEARCH CORPORATION Topic: CBD10107Current high-throughput platforms rely on labeled substrates that produce detectable spectroscopic signals upon reaction for monitoring enzyme catalytic activity. Add to that the high price tag for these instruments, ranging from several hundred thousand to millions of dollars, and there is a clear need for alternate solutions for a label-free, low-cost, high-throughput enzyme screening platform. ...
SBIR Phase II 2011 Department of DefenseOffice for Chemical and Biological Defense